 |
| Chrysalyne Schmults, MD, MSCE |
Chrysalyne Schmults, MD, MSCE, director of the Mohs and Dermatologic Surgery Center in the Department of Dermatology, received an R03 grant from the National Cancer Institute (NCI) for her research project, “Early Investigation of the Role of desmoplastic Fibrosis in Cutaneous Squamous Cell Carcinoma,” which will seek to discover why certain people with squamous cell skin cancer (SCSC) do not respond to treatment.
Schmults’ project will explore why abnormal fibrosis around squamous cell skin cancers is associated with metastasis and death. One goal of this work is to illuminate why treatment is ineffective for 50 percent of patients with SCSC that can’t be surgically removed.
More broadly at the Brigham, Schmults’ research focuses on high-risk cutaneous squamous cell carcinoma, clinical trials of staging and therapy for non-melanoma skin cancer, and costs associated with skin cancer surveillance and management.
The NCI leads, conducts and supports cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
